Following the demerger and premium listing of Haleon in July 2022, GSK initially retained a 12.94% stake in Haleon. As a result of the disposals, GSK has sold 1.19 billion shares in Haleon for ...

The share sale and buyback are expected to reduce Pfizer's interest in Haleon from 32% to approximately 24%. In its fourth-quarter release, Haleon added that it expects to allocate £500 million to buy ...

A nationwide recall of more than 40,000 units of toothpaste has received the lowest risk level by the Food and Drug Administration. A recall for Sensodyne Pronamel Active Shield Toothpaste for ...

And Sensodyne, alike many other brands from Haleon, is backed by years of scientific research and benefits from recommendations of professionals across its mix of products—it is the number one dentist ...

(Reuters) -Consumer healthcare firm Haleon said on Monday that U.S. drugmaker Pfizer will sell down its stake in the company to about 24%. Pfizer, which currently holds a 32% stake in Haleon, said ...

WARREN, N.J., Sept. 28, 2021 /PRNewswire/ -- GSK Consumer Healthcare (LSE/NYSE: GSK) is raising a cup – or two – of coffee to celebrate enjoying life's simple pleasures without the interruption of ...

The consumer healthcare group is aiming to close the site on a phased basis over the next two years. More than 400 jobs are to be axed at Sensodyne toothpaste and Advil painkillers firm Haleon as the ...

Haleon has announced that it is launching as an independent company 100% focused on consumer health, completing its demerger from GSK. The newly listed business is driven by its purpose to deliver ...

March 18 (Reuters) - Consumer healthcare giant Haleon HLN.L said on Monday that Pfizer PFE.N will sell about 630 million of its shares in the company, reducing the US drugmaker's stake to about 24%.

And Sensodyne, alike many other brands from Haleon, is backed by years of scientific research and benefits from recommendations of professionals across its mix of products – it is the number one ...